1. Home
  2. MXCT vs EVG Comparison

MXCT vs EVG Comparison

Compare MXCT & EVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

HOLD

Current Price

$0.79

Market Cap

160.0M

Sector

Health Care

ML Signal

HOLD

Logo Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest

EVG

Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest

HOLD

Current Price

$11.01

Market Cap

148.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MXCT
EVG
Founded
1999
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
160.0M
148.1M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
MXCT
EVG
Price
$0.79
$11.01
Analyst Decision
Buy
Analyst Count
4
0
Target Price
$7.50
N/A
AVG Volume (30 Days)
935.8K
49.4K
Earning Date
03-10-2026
01-01-0001
Dividend Yield
N/A
8.68%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$34,419,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$11.16
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.85
$9.13
52 Week High
$4.67
$10.86

Technical Indicators

Market Signals
Indicator
MXCT
EVG
Relative Strength Index (RSI) 13.73 53.11
Support Level $1.19 $10.88
Resistance Level $1.28 $11.05
Average True Range (ATR) 0.09 0.07
MACD -0.04 0.00
Stochastic Oscillator 7.23 44.44

Price Performance

Historical Comparison
MXCT
EVG

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

About EVG Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest

Eaton Vance Short Duration Diversified Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income with a secondary objective of seeking capital appreciation to the extent consistent with its primary goal. The portfolio of investments consists of business equipment and services, automotive, cable and satellite television, chemicals and plastics, food products, and other areas.

Share on Social Networks: